Business & Regulation

Margaret Hamburg, former FDA Commissioner, has led the agency through a period of increasing globalization.

Globalization has created an industrywide demand for regulatory harmonization. But who benefits?

Is age related to research productivity – and, if so, to what extent?

Record generic approvals, a joint opioid investigation... What’s new for pharma in business?

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.

Despite efforts to round up counterfeit criminals, fake medicines still find their way into supply chains.

Keeping close ties, locking-up loopholes, and calculating costs… What's new for pharma in business?

Data integrity is an important part of pharma, but not everyone knows how to handle it

Five gurus discuss the exciting developments in advanced medicine, and what the field needs to move forward.

In the growing field of advanced therapies, it's important to stick out from the crowd